Elixir Pharmaceuticals, a developer of metabolic disease drugs, has completed a $12 million equity financing led by MPM Capital, via MPM Bio IV NVS Strategic Fund. Additional investors in the round ...
MILPITAS, Calif. & PARIS--(BUSINESS WIRE)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced at EuroPCR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback